Daily Archives: August 16, 2021

Avian Influenza Vaccines Market to witness Huge Growth by 2027 | Type H5, Type H9 – The Market Writeuo – The Market Writeuo

Posted: August 16, 2021 at 1:40 pm

A2Z Market Research announces the release of the Avian Influenza Vaccines Market research report. The market is predicted to grow at a healthy pace in the coming years. Avian Influenza Vaccines Market 2021 research report presents an analysis of market size, share, and growth, trends, cost structure, statistical and comprehensive data of the global market. The Market report offers remarkable data regarding the industrys growth parameters, the current state of the market in terms of analysis of possible economic situations, and macroeconomic analysis.

The global Avian Influenza Vaccines market was valued at 1.03 Million USD in 2020 and will grow with a CAGR of 2.52% from 2020 to 2027.

Top Key Players Profiled in this report are Merial, CEVA, Zoetis, Elanco (Lohmann ), Merck Animal Health, Avimex Animal Health.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=544227

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

This report provides an effective business outlook, different case studies from various top-level industry experts, business owners, and policymakers have been included to get a clear vision about business methodologies to the readers. SWOT and Porters Five model have been used for analyzing the Avian Influenza Vaccines market on the basis of strengths, challenges and global opportunities in front of the businesses.

The global Avian Influenza Vaccines market is analyzed in terms of its competitive landscape. For this, the report encapsulates data on each of the key players in the market according to their current company profile, gross margins, sale price, sales revenue, sales volume, product specifications along with pictures, and the latest contact information. The reports conclusion leads into the overall scope of the global market with respect to feasibility of investments in various segments of the market, along with a descriptive passage that outlines the feasibility of new projects that might succeed in the global Avian Influenza Vaccines market in the near future.

Global Avian Influenza Vaccines market Segmentation:

Market by Type: Type H5, Type H9

Market by Application: Chicken, Duck & Goose

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Avian Influenza Vaccines market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Avian Influenza Vaccines market.

Get Customization on this Report:

https://www.a2zmarketresearch.com/enquiry?reportId=544227

The cost analysis of the Global Avian Influenza Vaccines Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

Reasons for buying this report:

Table of Contents

Global Avian Influenza Vaccines Market Research Report 2021 2027

Chapter 1 Avian Influenza Vaccines Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Avian Influenza Vaccines Market Forecast

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=544227

If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[emailprotected]

+1 775 237 4147

Global Thrombectomy Devices Market Report 2021 Global Industry Report, 2027

Fumigation Services Market Size, Share & Trends Analysis Report By Type (Natural Fumigation And Artificial Fumigation), by Application (Ants, Bed Bugs, Cockroaches, Termites, Beetles, Flies, Wasps, and Others), By End User (Commercial and Residential), Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America)Forecast till 2028

See the original post here:
Avian Influenza Vaccines Market to witness Huge Growth by 2027 | Type H5, Type H9 - The Market Writeuo - The Market Writeuo

Posted in Post Human | Comments Off on Avian Influenza Vaccines Market to witness Huge Growth by 2027 | Type H5, Type H9 – The Market Writeuo – The Market Writeuo

Australia’s Newcrest invests $181 million to expand open pit at Telfer mine – Reuters

Posted: at 1:38 pm

MELBOURNE (Reuters) -Newcrest Mining Ltd said on Thursday it had committed A$246 million ($181.4 million) to expand open pit mining at its Telfer operations in Western Australia, which will extend the operations for at least two years.

Australias largest listed gold miner said in a filing it had entered into a contract for work to proceed from one pit to the next at the gold, copper and silver mines in the states remote Paterson province.

This... is an investment in Telfers future which will ensure the operation is able to continue for at least the next two years, Chief Executive Officer Sandeep Biswas said.

With additional drilling, we believe there is the potential for further mine life extensions in the open pit and the underground beyond this time.

Telfer hosts the largest gold processing facility in the states remote Paterson Province where it produces gold dor and a copper-gold concentrate, and has capacity to process more.

But as the open pit mines have neared end of life, concerns have grown that its processing facility would run out of feed and become uneconomic.

The announcement signals increasing confidence around Newcrests big exploration find Havieron, which is nearby, said RBC in a note, which could feed into the Telfer processing circuit and lengthen its life.

We believe this opens up long-term optionality with Havieron and potential mine-life extension (at Telfer). The announcement today flags NCMs confidence in Havieron, it said in a report.

RBC values Havieron at around A$800m or ~A$1/sh for its 60% share in the project, which it owns with London-listed Greatland Gold and in which it can earn up to a 70% interest if it meets certain commitments.

Production stripping for the cutback will start next month, with first ore production expected to be delivered to the Telfer mine in March 2022, Newcrest said.

The announcement comes weeks after the miner reported a 5.4% drop in its June quarter output, following unplanned downtime at its Lihir mine in Papua New Guinea.

($1 = 1.3561 Australian dollars)

Reporting by Tejaswi Marthi in Bengaluru; Editing by Rashmi Aich and Michael Perry

Continue reading here:

Australia's Newcrest invests $181 million to expand open pit at Telfer mine - Reuters

Posted in Life Extension | Comments Off on Australia’s Newcrest invests $181 million to expand open pit at Telfer mine – Reuters

What Does It Mean to Live Forever? – OZY

Posted: at 1:38 pm

If 100 is already the new 80, what about living till youre 150 years old? Growing up, my dad, a doctor obsessed with the idea of immortality, would tell how his grandparents back in Lebanon had lived well past the 100-year mark. How? They simply ate well, he used to say, as if their secret was no mystery at all. But back in the mid-19th century, they were the exception to the rule: People generally died much, much earlier.

Today, as humans continue to lust after any number of material and immaterial objects, scientists are researching radical life extension technology like never before. Amazing, right? Lets see. Read on to learn about the great, the weird and the downright costly behind our quest for eternal existence.

Editors note: OZYs all about bringing you the new and the next . . . in fresh ways. Were trying a new look for your favorite newsletter to make your experience even more delicious. Please share your thoughts on the new look below.

Probably. Think about it: 200 years ago, there was no such thing as an active 90-year-old. Fast forward 20 decades, and photos of people breaching the 100-year barrier have become almost routine. Vaccines, antibiotics and a better understanding of what is good for our bodies and minds have taken us far. By 2050, the U.N. estimates there will be 3.7 million centenarians around the world, a major bump from the nearly 600,000 today. How can we push our biological clocks even more, keeping our minds sharp and bodies healthy for longer? One departure is to treat aging as an illness. Thats right. A tribe of scientists, including Steven Austad, a biologist at the University of Alabama, says the key to drastically longer life lies in altering the processes that prevent our very molecules from growing old.

Scientific progress looks promising. Experts have already successfully applied an antifungal used during organ transplants to extend the lives of mice. Just think what that might mean for a human. Thats not all. A string of revolutionary health treatments on the horizon is poised to change how our bodies deal with aging. Heard of a pill that mimics the benefits of exercise? Or drugs that trick our internal clock into thinking its younger? How about nano-robots that find and destroy disease inside our bodies and cell reprogramming? The future of anti-aging medicine is mind-blowing. But dont rush to your doctors office just yet. Despite such theoretical advances, some experts believe our bodies have a built-in expiration date. Not to mention theres a host of issues preventing humans from living longer that must be tackled, starting with poverty, violence, pollution, climate change and traffic accidents.

Can you imagine what you would do if you could live your peak years your 20s and 30s, say over and over? Maybe we use the [extra] years to reimagine the trajectory of life, just like we did 100 years ago, when we invented childhood and retirement, Austad said in a TED Talk. John Davis, a philosophy professor at California State University, Fullerton, brings a similarly philosophical lens to the question. I think people get wiser as they get older, he tells OZY. Given time and life experience, people become more patient, more aware of what a wise choice and a foolish choice looks like, and less violent. So we might find that a society that lives longer is a better society.

Now for the bad news. Increased pressure on already overstretched global health care systems and an inadequate supply of jobs, food and housing are just some of the challenges we face if we were to live for as long as wed like. Longer, healthier lives translate to expanding populations worldwide, a change the planet might not be able to withstand. We are already facing the consequences of overpopulation, Davis says. Its called climate change. The solution there remains controversial and might require something more radical than eternal life.

Outside the lab, futurologists have been putting forth their own takes on life extension. But be warned: you would need deep pockets to access them. Ray Kurzweil, a resident futurist at Google a company currently investing in the study of aging claims that by 2029, medical advances could start adding an additional year, every year, to peoples life expectancy, at least to those who can afford it. Researcher Aubrey de Grey posits that by 2036, many people with access to the right therapies (e.g., working to make our molecules younger) could avoid aging-related diseases or maladies entirely. Is there a catch? Unfortunately, yes. To reach the 150-year-old mark, you might need to live in an environment free of stressors and a wad of cash to cover what will be costly treatments. Tempted by whats being offered by Libella Gene Therapeutics, which claims to reverse aging by up to 20 years? Be prepared to fork over a whopping $1 million.

The price tag may be shocking, and it points to another disturbing truth: Longevity is set to become the new standard-bearer of inequality. And its not strictly a rich-country-versus-poor-country distinction, or even race, which is a major determinant of life expectancy in the U.S. A study by Northwestern University in Illinois found that Americans with a higher net worth at midlife live longer than their poorer counterparts. Even among brothers and sisters, those with greater wealth tend to outlive their siblings. Thats even taking into account identical genetic profiles, meaning the only factor that separates them is money.

Unless, that is, you happen to live in one of the worlds blue zones: a select group of countries in which people have been living longer for reasons unrelated to their bank account. Take Nicoya, for example. Centenarians in this lush Costa Rican peninsula say their secret to a long life is robust social networks and strong family ties. On the other side of the world, Japans super-senior citizens claim that healthy diets and exercise have paved the way to a lengthy and happy existence. Even if Kane Tanaka, the worlds oldest person at 118, admits she loves chocolate and soda. Money, however, can play a role. Just look at Monaco, the uber-wealthy principality where residents live on average to nearly 90 years old.

Dont live in any of those places? Dont despair. Someday there may be another option for those who want to live a lot, lot longer: Upload your consciousness, Black Mirror style. While we are still far from transferring our minds onto a chip, Artificial Intelligence advances could make this sci-fi-sounding proposition a reality. Some people have already signed on to a program to freeze their brains and bodies in liquid nitrogen coffins to preserve the essential parts of their personalities. Cryonics preserves the body until science has progressed to a point where a person could be reanimated and cured of whatever diseases they suffered from. In 2016, a 14-year-old girl with a rare form of cancer won the right to be cryogenically frozen after she died, in the hopes shell be brought back to life once a cure for her disease is discovered.

Yeah, we all know this one. Harvard researchers have found that increasing the amount of red meat you consume may, in some cases, raise the risk of early death. Participants in the experiment who increased their meat consumption by just half a serving per day (around 1.7 ounces) over eight years had a 10% higher risk of dying over the subsequent eight-year period. The studys authors also claim a significant benefit to replacing a portion of your weekly meals with non-meat options. Its not just good for you, its good for the planet. But Jeralean Talley, who lived to 116, might prove the authors wrong. This American super senior told Time in 2013 that one of the secrets to her longevity is a pork-rich diet, especially pigs ears and feet.

Walking an extra 1,000 steps a day could increase your chances of living a long life, according to the American Heart Association. The benefits of incorporating walking into your daily routine were consistent across people who took one long stroll and those who opted for shorter bursts throughout the day. That included going shopping or walking to your car. Heading out for a walk should be a priority for everyone, especially now that remote work is forcing many to park their butts for long stretches. Each increase of 1,000 steps was linked to a 28% decrease in the risk of early death.

When American Loreen Dinwiddie died in 2012 at age 109, she was the worlds oldest vegan. She credited her diet for helping her reach that milestone and for giving her a pep in her step. Its well-known that eating greens keeps you healthy day to day, but it also helps you live longer. Consuming five servings of fruits and veg every day translates to a 13% lower risk of early death. But dont despair, some fun is also allowed. Misao Okawa, the oldest person on the planet before she passed away in 2015 at age 117, said the secret to her long life was simple: eating delicious things including sushi and noodles.

You keep me young isnt just a sweet phrase. A study by researchers at the Boston University School of Medicine in 2014 found that late motherhood can lead to a longer life for women who delivered their last child after 33. In fact, they are twice as likely to live to 95 than those who had their last kid by 29. Furthermore, the New England Centenarian Study, published in 2014, concluded that women who bore children after turning 40 were four times more likely than younger mothers to reach 100 years old. Theres a caveat, though: Just delaying pregnancy wont make you live longer; growing old depends on your genes too. Read more here.

Read the original here:

What Does It Mean to Live Forever? - OZY

Posted in Life Extension | Comments Off on What Does It Mean to Live Forever? – OZY

Leading longevity researcher accused of sexual harassment – FierceBiotech

Posted: at 1:38 pm

Until this week, Aubrey de Grey was best known as the longevity researcher who predicted the first human to live 1,000 years may already be alive. Now, de Grey stands accused of being a sexual predator.

Celine Halioua, who received research funding from de Greys SENS Research Foundation, set out her accusations in a blog post titled Aubrey de Grey is a sexual predator. Laura Deming, founder of life extension VC shop The Longevity Fund, set out separate allegations against de Grey in her own blog post.

Deming wrote: I had one bad experience with him when I was 17he told me in writing that he had an adventurous love life and that it had always felt quite jarring not to let conversations with me stray in that direction given that [he] could treat [me] as an equal on every other level. He sent this from his work email, and Id known him since I was 14.

At the time, Deming said she wrote it off as a mistake. However, in the past few months, in part through conversations with Celine Halioua, Deming has come to believe her experience is part of a serial pattern hes enacted with women over whom hes in a position of power.

The accusations made by Halioua center on a dinner at which she was sat next to de Grey by a SENS executive. I was told to keep him entertained; Aubrey funneled me alcohol and hit on me the entire night. He told me that I was a glorious woman and that as a glorious woman I had a responsibility to have sex with the SENS donors in attendance so they would give money to him, Halioua wrote.

Halioua left that dinner sobbing and said it has taken her years to shake the deep-seated belief that I only got to where I am due to older men wanting to have sex with me. In the post, Halioua accused an unnamed SENS executive of harassing her so severely that she eventually dropped out of my PhD to escape him. Halioua is now CEO of a biotech startup developing drugs to extend dog life span.

De Grey responded to the accusations in a Facebook post. The longevity researcher admitted he inadvisedly wrote the email discussed by Deming and unreservedly regrets having done so. In all other regards, de Grey denies the accusations, which he framed as a setup.

I'm putting it out there right now: if other accusers come forward with supporting evidence, I will step aside a great deal faster than Cuomo just did. But if they don't who's the real culprit here? Hint: in my ever-so-personal view, it's not Celine or Laura. The unequivocally clear conclusion that I draw from the above is that they have been set up, de Grey wrote.

De Grey believes people have deceived Deming and Halioua into the view that I have done many things that I have in fact not done. As to who would orchestrate such a deception and why, de Grey said: I have been vigorously advised to keep my counsel on that question for another day or two but, as they say, watch this space.

SENS has put de Grey on administrative leave. An independent investigation into the allegations, which SENS first learned of in late June, is now underway.

More:

Leading longevity researcher accused of sexual harassment - FierceBiotech

Posted in Life Extension | Comments Off on Leading longevity researcher accused of sexual harassment – FierceBiotech

Melatonine market 2021 Global analysis, opportunities and forecast to 2027 | By Top Leading Vendors like Life Extension, Superior Supplement…

Posted: at 1:38 pm

The global Melatoninemarket is comprehensive and Insightful information in the report, taking into consideration various factors such as competition, regional growth, segmentation, and Melatonine Market size by value and volume. This is an excellent study specially designed to provide you with up-to-date information on important aspects of the Melatonine market. This report presents various market forecasts related to market size, production, revenue, consumption, CAGR, gross profit, price, and other key factors. Created using industry-leading primary and secondary research methods and tools.

TheMajorPlayers Covered in this Report:Life Extension, Jamieson Vitamins, Source Naturals, Pharmavite, Centrum, NOW Foods, Haviland Enterprises Inc., GNC, BY-HEALTH, Nutraceutical Corporation, Nutritional Supplement Manufacturers Inc., Softgel Nutraceuticals, Pharma Resources International LLC, Arnet Pharmaceutical, Van Wankum Ingredients, Spectrum Chemical Mfg. Corp., AIE Pharmaceuticals, Norquay Technology Inc., Action Labs Inc., Gemini Pharmaceuticals, Twinlab Corp., Superior Supplement Manufacturing, The Chemical Co.

In 2020, the global Melatonine market size was million US$ and it is expected to reach a million US$ by the end of 2027, with a CAGR between 2021 and 2027.

Get a Sample PDF Report:https://marketstrides.com/request-sample/melatonine-Market

Melatonine Market By TypesCapsulePillsLiquid

Melatonine Market By ApplicationsHospitalClinicHouseholdOther

Each part of the report contains important information about the global Melatonine market that can be used to drive strong growth in the coming years. A unique combination of primary and secondary research has enabled him to uncover hidden business opportunities in the global Melatonine market, gather meaningful insights from market participants, and obtain accurate market data. It covers a wide range of studies including production cost analysis, absolute dollar dividends, price analysis, business profiles, production and consumption analysis, and market dynamics.

Regional Analysis For Melatonine Market:

North America(United States, Canada, and Mexico)Europe(Germany, France, UK, Russia, and Italy)Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)South America(Brazil, Argentina, Colombia, etc.)Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

In this study, the years considered to estimate the market size of the Melatonine are as follows:

Grab Your Report at an Impressive Discount! Please click [emailprotected]https://marketstrides.com/check-discount/melatonine-Market

The study objectives of this report are:

For More Details On this Report:https://marketstrides.com/report/melatonine-Market

About Us:

Market Strides is a Global aggregator and publisher of Market intelligence research reports, equity reports, database directories, and economic reports. Our repository is diverse, spanning virtually every industrial sector and even more every category and sub-category within the industry. Our market research reports provide market sizing analysis, insights on promising industry segments, competition, future outlook, and growth drivers in the space. The company is engaged in data analytic and aids clients in due diligence, product expansion, plant setup, acquisition intelligence to all the other gamut of objectives through our research focus.

Contact Us:

Company Name: Market StridesContact Person: Nikolai EggerEmail: [emailprotected]Phone: +1 856 677 8909 (US)

View original post here:

Melatonine market 2021 Global analysis, opportunities and forecast to 2027 | By Top Leading Vendors like Life Extension, Superior Supplement...

Posted in Life Extension | Comments Off on Melatonine market 2021 Global analysis, opportunities and forecast to 2027 | By Top Leading Vendors like Life Extension, Superior Supplement…

Why Plastic Surgeons Say ‘On-the-Table’ Rhinoplasties Are Not to Be Trusted – NewBeauty Magazine

Posted: at 1:38 pm

No stranger to social media, Nashville plastic surgeon Daniel Hatef, MD relies on the visual tool of Instagram to showcase his practice, communicate with prospective clients, and share some of those oft-secretive, celebrity-treatment shots that even the most dedicated of patients arent always so quick to post.

One thing hes not a fan of: Something he refers to as the on-the-table rhinoplasty before-and-aftersan increasingly popular post he thinks looks amazing on the operating room table but, within a year, looks operated on.

The main reason is that the nose changes over time with healing, shares Dr. Hatef, when pressed on why hes not a proponent of showcasing the storied nose job surgery in this fashion. Classic reductive techniques done in closed rhinoplasty lead to dramatic aesthetic changes on the operating room table, and they are notorious for changing for the worse over time.

While he says his opinion is not to disparage the closed approachbut the classic pinched tips and supratip deformities that we often see with this technique dont show up until six-to-12 months postoperatively, if not longerhe strongly stands by the fact that, in rhinoplasty, you cannot base the favorability of a result based on the immediate postoperative appearance.

The reason: These pictures are typically taken from the profile view, Dr. Hatef explains. While this is fine for social media, when patients are looking for a rhinoplasty surgeon, they should ask to see frontal views as well. Although a change in the profile is almost always desired, this is the easier view to change.

Plus, he explains, plastic surgeons will take the before picture on the operating room table after theyve injected local anesthesia and epinephrine, which isnt necessarily indicative when playing a part in the final result.

We do these injections for pain control and to minimize bleeding, but they can be used to make the nose look biggerand the after result much more dramatic in comparison, he says. I encourage surgeons to post their operative before-and-afters, and I do the same. Its a great way to see how a result changes over time, but they should be taken accurately and before any injection is done.

And patients should know these things so that they can be more discerning in their choices.

Eugene, OR plastic surgeon Mark Jewell, MD backs the above and gives the life extension of our iPhones an equally as bad review.

Its impossible to show accurate outcomes in the operating room from a rhinoplasty, even if theres a discernable change, he says. And a phone picture of a nose taken before-and-after is, in my opinion, poor quality, non-standardized imaging. Rhinoplasty results need at least six months to mature and for swelling to completely resolve.

One case where it may be suitable, says La Jolla, CA plastic surgeon Robert Singer, MD: If it helps ease some post-surgery fears. It may be worthwhile to show the patient what was achieved at surgery during the time they are anxious and have their splint on. It is not, however, an adequate representation of the final result as swelling diminishes.

Encino, CA plastic surgeon George Sanders, MD is also not a fan of any kind of aesthetic result being photographed on the operating table. It is not the final result that is seen after months have passed since surgery, he says. Scar tissue, skin shrinkage, settling of the tissues and resolution of swelling all affect the final result that the patient will have. Granted, it takes time to acquire those long-termbefore-and-after photos, but theseare a much better indicator of the final surgical result than what is seen in the operating room.

Patients should insist on long-term before-and-after photos if they are going to rely on these as an indicator of the surgeons skill.

While she is quick to point out she doesnt do much rhinoplasty work, Pasadena, CA plastic surgeon Lily Lee, MD also stresses the fact that she is not a fan of the showing your immediate post-op work trend.

It is not a great for any part of the body, as so much changes throughout the healing process.

Nevertheless, New York facial plastic surgeon Konstantin Vasyukevich, MD says evaluating before-and-after pictures is still the best way to assess the rhinoplasty results.

However, the importanceof the timing for the after photos can not be overstated, he stresses. Few people realize that our nose is not just a static feature of our face, but rather a very complex mechanical structure. Multiple forces act on the cartilages of the nose simultaneously pulling it in all different directions. When these forces are in equilibrium, the nose will maintain its shape. When the forces acting on the cartilages are out of balance the nose will start changing its shape: becoming longer or shorter or more upturned or deviating to the side.

The art of rhinoplasty is being able to surgically balance all the forces acting on the nose, so the long term result does not differ from the result seen at the end of surgery. Therefore, taking a photo of the nose on the operating table can be quite misleading. If rhinoplasty surgery was expertly performed the nose will look the same in the years to come, alternatively, the nose could potentially look completely different just a few short month down the road.

At NewBeauty, we get the most trusted information from the beauty authority delivered right to your inbox

Find a NewBeauty "Top Beauty Doctor" Near you

Here is the original post:

Why Plastic Surgeons Say 'On-the-Table' Rhinoplasties Are Not to Be Trusted - NewBeauty Magazine

Posted in Life Extension | Comments Off on Why Plastic Surgeons Say ‘On-the-Table’ Rhinoplasties Are Not to Be Trusted – NewBeauty Magazine

Edwards Eager to Expand Father of Evolution’s Work | Newsroom – UC Merced University News

Posted: at 1:37 pm

It has been 186 years since Charles Darwin collected the samples of the Galapagos Islands species that led to his explanation of how the diversity of life on Earth has evolved and forever changed the way we understand the world.

During his five-week stay on the islands, Darwin collected dozens of samples, including one small, light brownish-grey snake on Floreana Island. That sample, now at the Natural History Museum in London, was the basis for describing a new species, the Galapagos (Floreana) racer.

The species disappeared from Floreana but can still be found on two satellite islands. Now, UC Merceds evolutionary biology and conservation genetics Professor Danielle Edwards and her research group are the first scientists to propose genetically sequencing Darwins original Galapagos racer sample. Edwards recently got a 202021 Research Publication Grant in Engineering, Medicine, and Science Grant through the American Association of University Women (AAUW) to study Galapagos snakes.

We want to effect ecosystem restoration on Floreana Island by finding an evolutionary replacement in the ecosystem for that species. To do this, we will sequence Darwin's specimen to understand the identity of the specimen relative to the populations present on other islands. We can then use the closest genetic relative to repopulate Floreana Island with this key predator, Edwards said. "We will also use this dataset to understand the extent of species diversity across the archipelago with the most extensive sampling to date."

Anecdotally, racer snakes have fallen prey to cats and other invasive species across the islands. Edwards and her team will use genetic data gathered from samples collected by Galapagos National Park and many international collaborators, along with specimens from museums, to assess population size changes in racer populations and see if populations are in decline, or stable, informing future conservation management efforts by the Galapagos National Park.

Its a huge effort, involving an international team of collaborators, and we do not yet know if we will be able to get DNA from the specimen Darwin collected, Edwards said. But we wont know unless we try, and results from other similar studies on museum specimens have shown promising results.

The Galapagos is a prime place to undertake conservation and rewilding research, because the park has an extensive record of incorporating rigorous science into practices with many partner organizations, she said.

Edwards will lead a team including colleagues from the United States, United Kingdom, Ecuador and New Zealand, and the Galapagos National Park and Island Conservation to develop the project. They have been collecting samples for the past five years to try and identify novel species on the islands and expand sampling to include all known islands and islets where snakes occur.

The findings of this research will provide a detailed picture of how snakes evolved across the islands. The snakes are the last reptile group to have their historical movements across the islands studied. They are believed to be the most mobile of the terrestrial vertebrates and are therefore more likely to provide insights into connections among islands, Edwards said. This project will also provide a source population for Floreana rewilding and a detailed assessment of the genetic health of snake populations across the islands.

Edwards, who joined the Department of Life and Environmental Sciences in the School of Natural Sciences in 2015, focuses most of her research on how the environment impacts the evolution of ecological niche, phenotype and behavior in reptiles, mostly in the context of how these changes lead to the development of new species. She applies this research to inform conservation management strategies for endangered and vulnerable reptiles and amphibians.

But this isnt her first genetics project in the Galapagos. In 2015, a team she was part of revealed that it had identified a novel species of Galapagos giant tortoise. Edwards conducted much of the population genetics analyses, using repeat fingerprinting markers like those used in forensic research, that let the team distinguish between two closely related species. She has been involved in projects in the Galapagos and Australia, applying genomic techniques to understanding biodiversity and implementing conservation management over the past 20 years.

Working in the Galapagos is a dream come true for an evolutionary biologist, herpetologist and conservation biologist, she said. I feel privileged and excited to work on a project based in the crucible of evolutionary thought with a specimen Darwin himself collected.

Here is the original post:

Edwards Eager to Expand Father of Evolution's Work | Newsroom - UC Merced University News

Posted in Evolution | Comments Off on Edwards Eager to Expand Father of Evolution’s Work | Newsroom – UC Merced University News

When insects lost their homes, evolution clipped their wings – The Indian Express

Posted: at 1:36 pm

New Zealands South Island was once covered in thick forest, the trees breaking like a dark green tide around the grassy mountaintops. After the arrival of Maori settlers about 750 years ago, some hillsides were cleared of their trees by humans using fire, and the foliage has not returned. For the organisms living in these forests, their habitat changed nearly overnight from sheltered woodland to exposed, windy grasslands.

Since the forests burned, little winged insects called stoneflies have changed as well, researchers have found. In a kind of evolutionary pivot over the course of just a handful of centuries, the stoneflies living above the tree line have lost the ability to fly, suggesting that human-made changes to an ecosystem, such as deforestation, can radically reshape the bodies of its inhabitants. The discovery was published in the journal Biology Letters.

Charles Darwin noticed that insects on islands have a curious tendency to be flightless, perhaps because flying is dangerous when you are tiny and winds are strong. In New Zealand, scientists had found flightless stoneflies on many different mountains, said Jon Waters, a professor at the University of Otago in New Zealand who is an author of the new paper. It was not initially clear why whether there was something about the altitude that favored a flightless form, or if there was something else going on.

To answer the question, he and his colleagues collected stoneflies at five sites, walking up through the forests onto the bald crests of the mountains. They caught insects as they went up the slopes, recording their locations. Looking at all the data, they were surprised to find a very clear trend.

We found that there was this amazing transition from winged populations to flightless populations as you go up, said Waters. Wherever we looked, that correlation was linked to where the trees stopped, not a particular altitude.

Because the switch happened at the tree line, rather than at a specific elevation, it suggests that the exposed situation above the trees has favored flightlessness in stoneflies. Perhaps, as in the case of Darwins island insects, wind on the heights makes flying a liability.

It is possible that in some places, even before the forests burned, there were already flightless stoneflies that simply expanded their territory after the fires. A genetic analysis of the stoneflies showed that three of the five populations the researchers looked at were quite different from their lowland winged brethren, implying that they may have been evolving on their own for a while.

The other two, however, had smaller differences, suggesting the change might be recent recent enough to be since humans arrived on the island.

The apparent swiftness of the change recalls the case of the peppered moth, whose coloration shifted from light to dark as air pollution from the Industrial Revolution in England darkened the trees it lived on; light moths, of course, were more visible to predators in their changed environment. It does not take millennia for animal populations to be altered by natural selection, these cases show.

You go into the trees, and youve suddenly gone into a different population. Its almost like magic that evolution seems to be working so clearly and so effectively over a short distance in some of these cases and a short time frame, Waters said.

Now the researchers are looking deeper into the genetics of the stoneflies to understand what it is that changes as the insects lose the ability to fly. The details may reveal whether stoneflies apparent flexibility arises from new mutations, or whether their flightlessness draws on variations that already existed in their ancestral populations and was just waiting for the right moment to take over.

This article originally appeared in The New York Times.

View original post here:

When insects lost their homes, evolution clipped their wings - The Indian Express

Posted in Evolution | Comments Off on When insects lost their homes, evolution clipped their wings – The Indian Express

Tailoring the evolution of BL21(DE3) uncovers a key role for RNA stability in gene expression toxicity | Communications Biology – Nature.com

Posted: at 1:36 pm

Restricting the evolutionary space of BL21(DE3) for the production of toxic proteins

In DE3 strains, the strong lacUV5 promoter drives expression of T7 RNAP, and it was previously shown that homologous recombination between lacUV5 and the weaker wild-type lac promoter is a dominating event that within hours of introducing a toxic gene leads to tolerance in BL21(DE3)15. To prevent this, we first genetically restricted BL21(DE3), creating a lacIlacZ variant by deleting exactly the part of the native lac locus that shared homology with the DE3 locus (Fig.1). In addition, this should prevent the expression of lacY, encoding the lactose permease, allowing a more uniform, concentration-dependent entry of IPTG into all cells in bacterial populations16.

a Illustration showing the experimental set-up used to restrict the evolutionary space for BL21(DE3) to overcome protein production toxicity on three levels: (upper panel) genetic restriction was accomplished by deleting a part of the BL21(DE3) genome that frequently recombines and lowers the T7 RNAP expression, (middle panel) protein production was coupled to both fluorescence and antibiotic resistance to prevent the formation of non-producing mutants and (lower panel) a spatiotemporally structured environment of ageing bacterial colonies was designed in order to identify strong phenotypic mutants. b Schematic of the workflow to produce layered agar plates that allow diffusion of the antibiotic ampicillin (AMP)and the inducer IPTG to allow sufficient time for colony formation on the surface of the top agar layer before toxic protein production is induced.

Next, similar to a previous study12, we chose the E. coli membrane protein insertase YidC coupled to GFP to serve as a model protein to investigate stress caused by membrane protein overproduction as it formerly was shown to have a strong negative fitness effect on E. coli17,18. The GFP fusion comes in handy for phenotypic restriction because it allows visual screening for mutants that still produce the fusion protein. We further restricted the evolutionary solution space by introducing a hairpin structure in the expression plasmid that couples YidC-GFP to the expression of a -lactamase gene19, providing resistance to ampicillin (Fig.1). This way, the formation of non-producing populations should be minimised in the presence of the antibiotic.

Finally, in contrast to the previous studies11,13,20, we aimed at introducing the protein production stress after bacterial colonies had established on plates. This spatiotemporally different approach should allow the formation of a large number of bacteria in a state of dormancy and in a structured environment, which previously was shown to constitute a unique evolutionary environment21. Furthermore, we speculated that mutants would be easy to identify as fluorescent secondary colonies, so-called papillae, outgrowing from the initially established colonies. To this end, two-layered agar plates were poured, allowing slow IPTG and ampicillin diffusion from the bottom to the top layer to grant sufficient time for colony formation before YidC-GFP production was induced (Fig.1).

During incubation for 1 week at 37C, we observed several fluorescent papillae (Fig.1) that were restreaked to confirm the fluorescent and ampicillin-resistant phenotype. Based on the fluorescence phenotype, the most promising mutants were isolated and cured of the YidC-GFP plasmid using a mild and simple CRISPR-based approach to plasmid curing22. These strains were subsequently retransformed with the original YidC-GFP plasmid to ensure that mutations leading to tolerance were localised on the genome and not on the expression plasmid. A single clone (Evo21(DE3)) was chosen for further characterisation.

To benchmark Evo21(DE3), we compared its ability to produce the YidC-GFP-fusion protein to the non-evolved BL21(DE3) wild-type strain as well as the derivative Mt56(DE3) previously described to be optimised for YidC-GFP overproduction12. The plasmid pLysS was utilised to limit basal T7 RNAP expression23 in BL21(DE3) and Evo21(DE3). Co-expression of pLysS in Mt56(DE3) is not relevant due to the greatly reduced polymerase activity in this strain. In liquid culture, based on GFP fluorescence, Evo21(DE3) expressed significantly (P0.0001) higher amounts of YidC-GFP than BL21(DE3) and Mt56(DE3). Eight hours post induction, yields were 3.6-fold higher in cultures of Evo21(DE3) than in cultures of BL21(DE3) and 2.1-fold higher than in Mt56(DE3) (Fig.2a). Parallel monitoring of the optical density of the cultures showed no major growth impairment for the strains (Supplementary Fig.1).

a Production of a toxic YidC-GFP-fusion protein in Evo21(DE3) compared to the non-evolved BL21(DE3) wild-type strain, the BL21(DE3)lacI/Z ancestor strain, and a previously evolved BL21(DE3) derivative Mt56(DE3). On the illustrated expression vector (pYidC), YidC-GFP production is translationally coupled to ampicillin resistance. b Fluorescence fold change between Evo21(DE3) and BL21(DE3), producing a library of 24 proteins of the E. coli inner membrane proteome C-terminally fused to GFP. c gfp expression levels in Evo21(DE3) and control strains with and without co-expression of the helper plasmid pLysS. d Western blot showing the expression of a camelid-derived single-chain antibody (nanobody) in Evo21(DE3) and control strains. Samples were normalised to cell density before loading. e Production of YidC under the control of a PrhaBAD promoter allowing titration of expression l-rhamnose. All fluorescence values displayed are normalised to OD at 600nm. Error bars indicated represent the average squared deviation from the mean (SD) of three biologically independent samples (n=3).

To assess whether the Evo21(DE3) phenotype was gene-specific, we next investigated the expression of a set of 24 different GFP-fusion proteins selected from an expression vector library of the E. coli inner membrane proteome24. These membrane proteins were selected to cover a wide range of functions, toxicity (previously reported as a change in OD600 upon IPTG addition24), and the number of predicted transmembrane domains (Supplementary Table1). Comparing the fold change of protein production in Evo21(DE3) and BL21(DE3), titre was improved for 19 of the 24 proteinswith a significant fold change of more than 1.5-fold for 14 of them (Fig.2b). The highest improvement was 6.1-fold (P0.001), observed for the protein YihG.

As a first test that the underlying mechanism allowing Evo21(DE3) to produce more toxic protein was not related to a general decrease in the activity of the T7 expression systemas previously observed for the BL21(DE3) derivatives C41/43(DE3), C44/45(DE3) and Mt56(DE3)we Sanger sequenced the T7 RNAP gene, which confirmed an absence of mutations. Next, we compared the expression of two non-toxic soluble proteins, GFP and a camelid-derived nanobody, and both were produced at higher levels in Evo21(DE3) than in BL21(DE3) or Mt56(DE3)both in the presence and absence of pLysS (Fig.2c, d). Similarly, Evo21(DE3) outperformed other strains in the production of seven out of eight different plant-derived cytochrome P450 enzymesa class of enzymes of significant biotechnological interest25 (Supplementary Fig.2). This indicates that the causative mutation in Evo21(DE3) is different from previously isolated BL21(DE3) derivatives and probably does not cause a general decrease in T7 RNAP activity.

Even though the screening for improved protein productivity was performed with the highly efficient T7 system, the ideal mutant strain would be capable of producing more protein independently from the promoter system. To explore if this was the case for Evo21(DE3), we replaced the T7 promoter with the l-rhamnose inducible rhaBAD promoter in the yidC-GFP expression vector, transformed it into Evo21(DE3), and expressed the construct by inducing with different rhamnose concentrations in liquid culture. With concentrations of 5 and 20mM l-rhamnose, Evo21(DE3) produced significantly (P0.0001) more protein than BL21(DE3) and Mt56(DE3) (Fig.2e).

In summary, this initial characterisation shows that the evolved strain can produce a higher titre of a range of different proteins using a T7-system-independent mechanism.

The phenotype of Evo21(DE3) prompted us to sequence the strain using Illumina whole-genome sequencing. Two point mutationsone in the argE and one in the fecB locus (Fig.3a)and an insertion of a mobile IS1 element into the rne gene were identified. Upon reintroduction of the argE or fecB point mutations into BL21(DE3) by oligonucleotide-based recombineering, the YidC-GFP overexpression phenotype was not obtained (data not shown), whereas, when reintroducing the truncation of the rne locus into BL21(DE3) and the Evo21(DE3) parental BL21(DE3) lacIlacZ strain, the YidC-GFP overexpression tolerance phenotype was nearly identical to Evo21(DE3) (Fig.3b). This makes it highly likely that the rne IS1 insertion is the main causative mutation in Evo21(DE3).

a Illustration of mutations in the Evo21(DE3) genome compared to the ancestor BL21(DE3). Whole-genome sequencing of mutant strain Evo21(DE3) revealed two point mutations (grey) and a truncation of the rne gene caused by the transposition of a mobile element IS1 into the locus. The deletion of the genomically shared homology sequence in the BL21(DE3) ancestor strain with the DE3 area (335,401337,123) is annotated. b Production levels of the toxic YidC-GFP-fusion protein in Evo21(DE3) compared to BL21(DE3), as well as BL21(DE3) and the non-evolved ancestor strain BL21(DE3)lacIlacZ after reintroducing the rne truncation by recombineering. Error bars indicated represent the average squared deviation from the mean (SD) of three biologically independent samples (n=3). c Illustration of the E. coli RNA degradosome. N- and C-terminal domain of the membrane-bound essential endonuclease RNase E (blue) and the localisation of associated enzymes PNPase, Rhlb and enolase along the C-terminal non-catalytic scaffolding region are displayed. Mutations of the rne gene in Evo21(DE3), BL21Star(DE3) and rne* gene harboured on pLysS-Max are indicated.

The identified IS1 insertion causes a truncation of the encoded 1061-residue E. coli endoribonuclease RNase E after amino acid 702 and, therefore, a polypeptide lacking the last 359 residues of its C-terminus in Evo21(DE3) (Fig.3c). RNase E is an essential membrane-associated enzyme involved in the maturation of both ribosomal RNA and tRNA, as well as total mRNA decay, and mediates the assembly of a multi-enzyme complex referred to as the RNA degradosome (Fig.3c). It has previously been shown that only the N-terminal half (1529) of RNase E, accommodating the active catalytic domain, is essential for cell growth, and the C-terminal non-catalytic region is mostly disordered and known to function as a scaffold mediating the association of the enzymes PNPase, Rhlb and enolase26,27,28.

Interestingly, a similar truncation of the rne locus, rne131, resulting in an RNase E polypeptide lacking its non-catalytic region (amino acid residues 1584, Fig.3c) was isolated in a screen for suppressors of a temperature-sensitive allele of the mukB gene26. A later study showed that in strains such as BL21(DE3), introducing the rne131 truncation caused a bulk stabilisation of mRNA degradation, including mRNA produced by T7 RNAP29. The rne131 truncation was engineered into the commercially available BL21Star(DE3) with the rationale that stabilising bulk mRNA would result in increased protein production. However, following the same rationale, the commercial strain also comes with a note suggesting that it might be unsuitable for overexpression of toxic genes.

We compared the expression of six different genes that we previously found expressed better in Evo21(DE3) than in BL21(DE3) with expression in BL21Star(DE3) and found expression levels to be highly similar between BL21Star(DE3) and Evo21(DE3) (Fig.4a). This provides an independent confirmation that the phenotype of Evo21(DE3) is caused by the truncation of rne.

a Heterologous production of a variety of non-toxic and toxic GFP-fusion proteins in Evo21(DE3) and BL21Star(DE3), both harbouring different truncations of the rne gene, compared to BL21(DE3). b Expression of the same genes in Evo21(DE3) is compared to expression in BL21(DE3) when co-expressing either the auxiliary plasmid pLysS or pLysS-Max. c Schematic illustration of the plasmid pRNE-GFP designed to report on RNase activity. Promoters controlling rne expression are indicated (P14)49,50. The expression level of the rne gene can be monitored in vivo via GFP fluorescence signal. d Exploration of the pRNE-GFP reporter plasmid in BL21(DE3) derivatives. Different levels of RNase activity can be monitored in the strains. e Titration of yidC expression in Evo21(DE3), BL21Star(DE3) and BL21(DE3) via increasing levels of l-rhamnose and its effect on the rne regulon expression reporting RNase activation in the cell during toxic membrane protein production. Upper half: Fluorescence corresponds to YidC-GFP production levels. Lower half: Cells harbour both the rne reporter plasmid (pRNE-GFP) and pPrhaBAD-YidC controlling yidC expression (no GFP fusion). Fluorescence levels correspond to GFP produced under the control of the rne regulon. f Effect of the pLyS-Max auxiliary plasmid on RNase activity. Plasmids pLysS and pLysS-Max are co-expressed along with pRNE-GFP in BL21(DE3) cells. To repress leaky expression of the rhamnose promoter controlling rne* expression on pLysS-Max, 0.4% glucose was added where indicated. Error bars indicated represent the average squared deviation from the mean (SD) of three biologically independent samples (n=3).

The way Evo21(DE3) was isolated from papillae outgrowing colonies on week-old agar plates, and because dominant rne mutants previously have been observed30, made us speculate that different rne variants could be studied by simple co-expression from a plasmid in the presence of wild-type rne on the genome. To test this idea and to compare different variants of the rne gene at different expression levels, we cloned rne variants in front of the rhaBAD promoter on the pLysS plasmid backbone: full-length rne, the Evo21(DE3) and BL21Star(DE3) truncated versions and a version with a further truncation in the membrane-binding domain of RNase E. However, none of these constructs showed any positive effect on YidC-GFP expression (Supplementary Fig.3).

Serendipitously, we isolated a spontaneously occurred rne mutant, called rne*, and included it in our analysis. We found that rne* provided on the pLysS plasmid (hereafter called pLysS-Max) could increase YidC-GFP production even further than Evo21(DE3) (Fig.4b). The rne* mutation converts the essential31 aspartate residue in position 346 to an asparagine in the so-called DNase I subdomain of RNase E involved in chelating an essential Mg2+ ion. The aspartate residue is believed to act as a general base to activate the attacking water essential for the catalytic activity of the enzyme32. The replacement of Asp-346 with the polar amino acid Asn was previously shown to decrease RNA cleavage by about 25-fold32. The effect of expressing rne* was not gene-specific as the effect was preserved for three out of four other tested genes (Fig.4b). This provides an alternative demonstration that manipulating with rne severely affects recombinant protein production and provides a simple tool, in the form of an auxiliary pLysS-Max plasmid that can be transformed into other strains, to improve protein production titre.

The positive effect of rne truncations such as rne131 on protein production was previously assumed to be due to the stabilisation of the recombinant mRNA29. However, the observation that the rne truncation in Evo21(DE3) leads to tolerance of toxic gene expression suggests a broader role involving balancing of RNA levels more globally.

Autoregulation allows RNase E to continuously adjust its synthesis to that of its substrates by controlling the degradation rate of its own mRNA33,34. This could work as a biosensor for RNase E activity by fusing the promoter and 5end of rne with a genetic reporter, as previously demonstrated with lacZ34. To explore RNase E activity in our evolved strains for recombinant protein production, we constructed a similar RNase E biosensor (pRNE-GFP) using GFP as a reporter (Fig.4c).

We transformed the pRNE-GFP reporter into BL21, BL21(DE3), BL21Star(DE3), Evo21(DE3) and Mt56(DE3) and monitored fluorescence in a microplate reader under conditions similar to the typical protein production scenario. Surprisingly, under these conditions, fluorescence was 14-fold reduced in Evo21(DE3) and sevenfold reduced in BL21Star(DE3) compared to the ancestral BL21(DE3 (Fig.4d). Given that Evo21(DE3) behaves almost identically to BL21Star(DE3) and that the rne131 truncation has been shown to cause a bulk stabilisation of mRNA degradation29, this suggests that low fluorescence from our reporter correlates with increased bulk mRNA stabilisation. Interestingly, fluorescence from the reporter was reduced approximately twofold in BL21 compared to BL21(DE3), suggesting an effect of the DE3 locus itself on RNase E activity in the cell.

Next, we wanted to explore if the expression of YidC-GFP affected RNase E activity in the different strains. To this end, because YidC-GFP cannot be expressed from the T7 promoter in BL21 (no T7 RNA polymerase) or BL21(DE3) (no growth), we expressed it from the rhaBAD promoter construct (Fig.2e) using different concentrations of rhamnose. This showed that YidC-GFP levels could be titrated with rhamnose and confirmed higher expression in BL21Star(DE3) and Evo21(DE3) than in the other strains at high rhamnose concentrations (Fig.4e, upper half).

To monitor fluorescence from the RNase E GFP reporter, we then deleted GFP from the YidC construct and attempted to co-transform it with pRNE-GFP into different strain backgrounds (Fig.4e, lower half). However, we were unable to recover and grow transformants in BL21(DE3) and BL21Star(DE3), suggesting a lethal imbalance in RNA levels caused by the presence of these two plasmids. We were able to recover and grow double transformants in BL21, Evo21(DE3), and Mt56(DE3) and monitor fluorescence as an indication of RNase E activity. Fluorescence increased to high levels upon increasing the concentration of rhamnose in BL21 and Mt56(DE3), but fluorescence levels were at least 2.5-fold lower (at 1mM rhamnose) in Evo21(DE3) and hardly increased upon further rhamnose addition. This suggests that RNase E activity towards bulk mRNA is increased when yidC expression is increased but that the activity is lower in Evo21(DE3) than in the other strains (Fig.4e).

Finally, we explored the effect of the pLysS-Max auxiliary plasmid (harbouring the mutant rne*) on RNase E activity by co-transforming it along with pRNE-GFP into BL21(DE3). As controls, we included a strain co-transformed with pLysS and pRNE-GFP and BL21(DE3) transformed only with pRNE-GFP. Because we previously observed effects on RNase E activity due to the presence of the DE3 locus, we repressed leaky expression of T7 RNAP from the lacUV5 promoter by adding glucose to the medium and titrated rne* levels with rhamnose. In the absence of glucose and the presence of pLysS, we observed an increase in fluorescence which was repressed by expression of rne* (Fig.4f). This shows that the pLysS-Max plasmid can be used to regulate RNase E activity in the cell.

Continue reading here:

Tailoring the evolution of BL21(DE3) uncovers a key role for RNA stability in gene expression toxicity | Communications Biology - Nature.com

Posted in Evolution | Comments Off on Tailoring the evolution of BL21(DE3) uncovers a key role for RNA stability in gene expression toxicity | Communications Biology – Nature.com

Acquisition and Positive Revisions Drive Substantial Increase in Evolution Petroleums Proved Reserves for Fiscal Year-End 2021 – Yahoo Finance

Posted: at 1:36 pm

HOUSTON, TX / ACCESSWIRE / August 16, 2021 / Evolution Petroleum (NYSE American:EPM) ("Evolution" or the "Company") today announced its reserves as determined by its independent reserve engineer, DeGolyer & MacNaughton, for the fiscal year ended June 30, 2021.

Highlights:

Diversified its portfolio through the acquisition of long-life producing assets in the Barnett Shale adding 13.1 million barrels of oil equivalent ("MMBOE") to its reserves

Substantially increased fiscal year-end proved reserves to 23.4 MMBOE from 10.2 MMBOE at fiscal year-end 2020

Positive reserve revisions net of production due primarily to the return to service of the Delhi CO2 supply line and well reactivations at Hamilton Dome

Reserves based on trailing twelve-month commodity prices that are substantially below current prices

Jason Brown, President and Chief Executive Officer, commented, "We were pleased to more than double our fiscal 2021 year-end proved reserves with the acquisition of a non-operated ownership interest in Barnett Shale natural gas assets in May 2021. The associated proved developed producing (PDP) reserves are anchored by a low annual decline of less than 10% and include potential upside through workover opportunities. The acquisition of the Barnett Shale assets helped to diversify our production mix to include natural gas with favorable access to the Gulf Coast markets that offer premium pricing. Additionally, we had positive reserve revisions this year at Delhi and Hamilton Dome, further demonstrating the strength and value of our existing long-life producing assets. We were encouraged by the return to service of the CO2 supply line to Delhi in late 2020 that will allow resumption of normal injection levels and provide meaningful reservoir pressure support for the continued recovery and development of the field's long-life reserves. At Hamilton Dome, the operator was able to return substantially all of the wells shut-in due to the dramatic price drop caused by the pandemic, adding to production and extending the life of the field. Hamilton Dome reserves were also revised upward due to improved year-over-year pricing. We look forward to continuing to benefit from the improved price environment as we evaluate and execute additional opportunities to further grow our asset base and reserves."

Story continues

As of June 30, 2021

Oil

NGL

Natural Gas

Equivalent

MBO

MBL

MMcf

MBOE*

Proved Developed Producing

6,815

6,663

48,571

21,573

92

%

Proved Undeveloped

1,605

209

-

1,814

8

%

Total Proved

8,420

6,872

48,571

23,387

100

%

Probable Developed Producing

2,052

743

-

2,795

85

%

Probable Undeveloped

489

-

-

489

15

%

Total Probable**

2,541

743

-

3,284

100

%

Possible Developed Producing

2,251

314

-

2,565

91

%

Possible Undeveloped

255

-

-

255

9

%

Total Possible**

2,506

314

-

2,820

100

%

* Equivalent reserves based on a ratio of 6 Mcf of natural gas to 1 Bbl of oil.

** Read the section captioned "Cautionary Statement" later in this release addressing reserves.

Proved Reserves

The Company's year ended June 30, 2021 SEC proved reserves were 23.4 MMBOE, up from 10.2 MMBOE at year ended June 30, 2020. Although both Delhi and Hamilton Dome had positive revisions net of production, the majority of the increase was due to the acquisition of non-operated interests in the Barnett Shale in May 2021 that added 48.6 Bcf of natural gas, 4.9 MMBL of natural gas liquids, and 0.1 MMBO of oil proved reserves (13.1 MMBOE).

The SEC pricing (twelve-month first day of the month average realized prices) used in the report for the year ended June 30, 2021 was $49.72 per barrel of oil and $2.46 per MCF of natural gas. For fiscal year ended June 30, 2020, SEC average realized prices were $47.37 per barrel of oil and $2.12 per MCF of natural gas.

Approximately 65% of year ended June 30, 2021 SEC proved reserves were liquids (36% crude oil and 29% NGLs) and 35% natural gas. At fiscal year-end, approximately 92% of proved reserves were classified as proved developed producing and 8% as proved undeveloped.

Probable and Possible Reserves

The probable and possible reserves are categories that represent potential recoveries from the CO2 flood developed in the Delhi Field greater than those included in the proved reserves. Consequently, while the probable and possible reserves are 85% and 91% developed, respectively, and require de minimis capital expenditures, they remain less certain of attainment and have more risk of recovery than proved reserves and should not be aggregated with other categories. These categories of reserves reflect the incremental reserves associated with different engineering assumptions with respect to the percentage of original oil in place that can be recovered through CO2 enhanced oil recovery. Probable and possible reserves decreased approximately 1% and 8%, respectively, from the prior year primarily due to the movement of probable and possible reserves to the proved reserves category as a result of a positive change to the proved reserves life at Delhi

Investor Conference Presentation

Evolution today announced that the Company will participate in EnerCom's The Oil & Gas Conference in Denver, Colorado on August 17, 2021. The Company's presentation will be webcasted and is scheduled to be available at 11:40 am Eastern (10:40 a.m. Central) on August 17, 2021. The presentation can be accessed through the EnerCom conference portal for registered participants at https://www.theoilandgasconference.com, or in the investor relations section of the Company's website: http://www.EvolutionPetroleum.com.

About Evolution Petroleum

Evolution Petroleum Corporation is an oil and natural gas company focused on delivering a sustainable dividend yield to its shareholders through the ownership, management, and development of producing oil and natural gas properties onshore in the United States. The Company's long-term goal is to build a diversified portfolio of oil and natural gas assets primarily through acquisition, while seeking opportunities to maintain and increase production through selective development, production enhancement, and other exploitation efforts on its properties. Our largest assets are our interest in a CO2 enhanced oil recovery project in Louisiana's Delhi Field, our interest in a secondary recovery project in Wyoming's Hamilton Dome Field, and our recently acquired interest in the Barnett Shale in Texas. Additional information, including the Company's annual report on Form 10-K and its quarterly reports on Form 10-Q, is available on its website at http://www.EvolutionPetroleum.com.

Cautionary Statement

All forward-looking statements contained in this press release regarding current expectations, potential results and future plans and objectives of the Company involve a wide range of risks and uncertainties. Statements herein using words such as "believe," "expect," "plans," "outlook," "should," "will," and words of similar meaning are forward-looking statements. Although our expectations are based on business, engineering, geological, financial, and operating assumptions that we believe to be reasonable, many factors could cause actual results to differ materially from our expectations and we can give no assurance that our goals will be achieved. These factors and others are detailed under the heading "Risk Factors" and elsewhere in our periodic documents filed with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.

Our reserves as of June 30, 2021 were estimated by DeGolyer & MacNaughton, a global independent reservoir engineering firm. All reserve estimates are continually subject to revisions based on production history, results of additional exploration and development, price changes and other factors. The SEC's current rules allow oil and gas companies to disclose not only proved reserves, but also probable and possible reserves that meet the SEC's definitions of such terms. Estimates of probable and possible reserves by their nature are much more speculative than estimates of proved reserves. These non-proved reserve categories are subject to greater uncertainties and the likelihood of recovering those reserves is subject to substantially greater risk. When estimating the amount of oil and natural gas liquids recoverable from a particular reservoir, probable reserves are those additional reserves that are less certain to be recovered than proved reserves but which, together with proved reserves, are as likely as not to be recovered, generally described as having a 50% probability of recovery. Possible reserves are even less certain and generally require only a 10% or greater probability of being recovered. These three reserve categories have not been adjusted to different levels of recovery risk among these categories and are therefore not comparable and are not meaningfully combined.

Company Contacts:

Jason Brown, President & CEOJBrown@evolutionpetroleum.com(713) 935-0122

Ryan Stash, SVP & CFORStash@evolutionpetroleum.com(713) 935-0122

SOURCE: Evolution Petroleum Corporation

View source version on accesswire.com: https://www.accesswire.com/659842/Acquisition-and-Positive-Revisions-Drive-Substantial-Increase-in-Evolution-Petroleums-Proved-Reserves-for-Fiscal-Year-End-2021

Go here to read the rest:

Acquisition and Positive Revisions Drive Substantial Increase in Evolution Petroleums Proved Reserves for Fiscal Year-End 2021 - Yahoo Finance

Posted in Evolution | Comments Off on Acquisition and Positive Revisions Drive Substantial Increase in Evolution Petroleums Proved Reserves for Fiscal Year-End 2021 – Yahoo Finance